Background: There are limited data regarding impact of chronic alcohol use on vasospastic angina. We evaluated the impact of alcohol use on coronary artery spasm (CAS) as assessed with intracoronary acetylcholine (Ach) provocation test. Methods: A total 3034 consecutive patients [pts, Men 1457 (48.0%), mean age 54.5Ϯ12.4 years who underwent coronary angiography with Ach provocation test were enrolled. Study population were divided into current alcoholic (912, 30.1%) vs. non alcoholic (2101, 69.2%) groups. Significant CAS was defined as transient Ͼ70% luminal narrowing with chest pain and/or ST segment changes. Results: Baseline clinical characteristics were balanced except non alcoholic had more hypertension (49.3% vs. 40.4%, PϽ0.001), diabetes (13.6% vs. 10.2%, Pϭ0.009), peripheral vascular disease (6.3% vs.3.0%, PϽ0.001), history of CVA (3.5% vs.2.1%, Pϭ0.041), congestive heart failure (2.0% vs.0.5%, Pϭ0.004) whereas alcoholic group were mostly men (76.5% vs.35.8%,PϽ0.001) and had more current smokers (42.8% vs. 13.8%,PϽ0.001). Although the alcoholic group showed higher incidence of myocardial bridge, Ach induced CAS, and severe narrowing on QCA on univariate analysis, however, after adjusting the baseline differences, all clinical and angiographic parameters of Ach provocation test were not different between the two groups (Table) . Conclusions: In our study, current alcohol use was not associated with clinical and angiographic characteristics of CAS as assessed with Ach provocation test.
Background: Ergnovine(Erg) and Acetylcholine (Ach)isanuseful agent forassessing significant coronary artery spasm (CAS). However, clinical data regardingcombined or simultaneous intracoronary provocation test using these two agents are largely unknown. Methods: A total 113consecutive patients (pts)underwent Ergand/ or Ach provocation test were enrolled. Erg test was performed by incremental doses of 5, 10, 25ug. If Erg test is (-) , subsequentAch test was done by 20, 50, 100ug. Significant CAS was defined as focal or diffuse severe transient luminal narrowing (Ͼ70%) with/without chest pain or ST-T change on ECG. We investigated the overall results of simultaneous Erg and Ach provocation test. Results: Baselineclinical characteristics showed that mean age was 53.18 Ϯ 9.8 years old (male 69.3%), hypertension 48.7%, diabetes 6.1%, dyslipidemia 12.2% and smoking 34.6%. A total 49pts (49/113, 43 .4%) showed (ϩ) provocation test by Erg. Sixteen % of the pts responded to E2 dose (10ug) and 83.6% to E3 (25ug) . Multivesselspasm was in 32.7%, and diffuse spasm 16.3%. A total 64 pts who were (-) to Erg test underwent Ach provocation test. A total 60 pts (60/64, 93.8%) showed (ϩ) provocation test by Ach. Eleven % of the ptsresponded to A1 dose (20ug) and 35.0% to A2 (50ug). Multivesselspasm was in 47.5%, and diffuse spasm 8.3%. Only 4 pts (4/113, 3.5%) were (-) response to both Erg and Ach test. Conclusion: Both Erg and Ach were safe but Ach was more sensitive and Erg seems to be more specific to show significant CAS.
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Serum Neutrophil Gelatinase-associated Lipocalin (ngal) In Diabetic Patients With Renal Impairment Patients Undergoing Elective Coronary Angiogram In University Malaya Medical Centre
Johan R Ismail UITM, SHAH ALAM, Malaysia
Serum NGAL as a biomarker for subclinical contrast induced nephropathy (CIN) in diabetic patients with renal impairment at 24 hours post coronary catheterization. Background: Serum NGAL has been shown to be a novel biomarker for acute kidney injury. Studies done previously showed that serum NGAL level peak at 4 hours after the administration of a contrast agent as opposed to serum creatinine. Recently the term 'subclinical acute kidney injury' plays an important role, as it increases morbidity and mortality. Using serum NGAL as a marker, we aim to uncover the incidence of subclinical CIN on a population of diabetic patients with renal impairment undergoing elective coronary angiogram in Cardiology Unit University Malaya Medical Centre. Objectives: To evaluate incidence of subclinical CIN in diabetic patients with renal impairment undergo elective coronary angiogram using new and conventional biomarker. Methodology: This is a prospective study of 70 consecutive patients who fulfilled the following inclusion criteria:
1. Elective admission for coronary angiogram. The blood samples were taken at 0H; 4H and 24H post coronary angiogram and sent for serum creatinine (sCr) and NGAL measurement using Alere Triage® NGAL Test. Results: Out of the 70 samples taken, 25.7% received intravenous saline infusion and oral N-acetyl-cysteine (NAC) for CIN prophylaxis. Mean age of the patients was 66.8 Ϯ 4.7 years with mean estimated GFR of 45.3 Ϯ 13.6 mls/min/1.73m2. Twelve point eight percents (12.8%) patients were diagnosed as CIN based on increment 25% serum creatinine from the baseline. There was a significant raised of serum NGAL at 4 hours after contrast administration in 77.1% of the patients without raised serum creatinine suggesting subclinical acute kidney injury. The magnitude of NGAL increment was significantly lower in the goups receiving CIN prophylaxis (4.8 ng/ml vs 42.3 ng/ml, p Ͻ 0.001), suggestive protective effect of prophylaxis. Conclusion: Serum NGAL level is a useful acute clinical marker for CIN post coronary angiogram in high-risk patients as the level raised as early as 4H compared to serum creatinine. Our high-risk cohort has 77.1% incidence of subclinical AKI, higher compared to previous study. Patients who received CIN prophylaxis had lesser magnitude of tubular injury compared to those who were not given. Introduction: Frequency and gravity of heart failure (HF) led to the need for precise risk stratification. The association with renal failure worsens the prognosis. Cystatin C, an accurate glomerular filtration rate (GFR) marker, may have a prognostic value in heart failure patients. Aim: To evaluate the mortality predictive value of Cystatin C in patients with HF. 
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Methods: We prospectively included patients admitted to our department for acute HF or exacerbation of chronic HF between December 2010 and May 2011. We excluded patients over 80 years old, those with severe renal failure (GFR Ͻ 50ml/min/1.73 m2) or severe worsening of renal function during hospitalization and patients having dysthyroidism or under immunosuppressive therapy. A dosage of plasmatic cystatin C concentration was done using particule-enhanced turbidimetric immunoassay method. The main endpoint was death at a 120 days follow up. Results: Sixty four patients were enrolled, aged 62.2 Ϯ 11.4 years, with a sex ratio of 1.56. Patients were at NYHA class III or IV at admission in 87% of cases, with an ischemic etiology in 55% of cases. LVEF was 51.7 Ϯ 13.8% and GFR was 76 Ϯ 19.8 ml/min. Mean cystatin C was 1.42 Ϯ 0.37 mg/l. During follow-up, 10 (15.6%) patients died. Higher levels of Cystatin C (third tertile) were associated with a significant increase in mortality rate with an RR of 8 when moving from the first to the third tertile and a RR of 3 when moving from the second to the third (pϭ0.033). Prognostic value is uncertain for milder elevations between the first and second tertiles (pϭ0.45). Conclusion: A high level of Cystatin C at admission is a strong predictor of 120-days mortality among patients with HF. Discriminative value falls for milder elevations.
CRT-120 Neointimal Contractility Inside Of Stent: IVUS Observation In a Porcine Coronary Model
Hiroyuki Nagai, 1 Jinsheng Li, 2 Yawei Xu, 3 Wei Chen, 3 Yidong Wei, 3 Weiming Li, 3 Spencer B King, 2 Nicolas Chronos, 2 Dongming Hou 2 1 Division of Cariology, Sakurabashi-Watanabe Hosp., Osaka, Japan 2 SJTRI, Atlanta, GA; 3 Cardiology department, 10th hosp., Shanghai, China Aims: QCA after intracoronary Acetylcholine (Ach) infusion is used to evaluate of coronary vasomotor dysfunction following stent implantation, which diameter changes of non-stented segment was observed. In this case study, IVUS was utilized to analyze the vasomotion within stented segment in a porcine coronary artery model. Methods and Results: Everolimus-eluting stent (3.0x18mm) was implanted to RCA with S/A of 1.1:1. At 28d, vasomotion was assessed by infusion of Ach 10-6 M/ml 3 min followed by NTG 200g. An IVUS catheter was inserted to the mid of the stented segment without pullback. IVUS imaging was recorded before, during Ach infusion, as well as after NTG infusion. Finally, the animal was terminated for histology and immunhistochemistry.
Angiographically, the RCA was widely patent with TIMI III flow post stent implantation and at follow-up. Neointimal contraction and relaxation in response to Ach and NTG were demonstrated by IVUS (Figures), which measured by the changes of neointimal hyperplasia area (NIA), as well as luminal area (LA). The maximal NIA inside of the stent was 1.3 fold increasing from its baseline level during Ach infusion. In counter to increasing of neointimal area, the minimal LA was reduced 30%. Following NTG injection, the NIA was returned to baseline level. The stent area (SA) from IVUS was consistent during this provocative test. Histology demonstrated fibrocellular neointimal formation in the stented vessel segment. Immunohistochemistry for ␣-actin showed positive smooth muscle cell staining in the neointima. Conclusions: This is the first report using IVUS to observe vasomotion within stented segment in porcine model at 28d. Our results showed that the neointima in the stented segment had contractility in response to Ach challenge. Scaffolding by metal stent plays a role to compromise the consequence of vessel spasm.
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Effectiveness Of Implementing A Therapeutic Hypothermia Protocol In Cardiac Arrest Patients: A Singapore Tertiary Center Experience Shir Lynn Lim, Benjamin Leong, Joshua P Loh, Toon Wei Lim National University Health Systems, Singapore, Singapore Introduction: Out of hospital cardiac arrest (OHCA) is a major cause of unexpected deaths in Singapore with an OHCA survival-to-hospital-discharge rate of 2%. Therapeutic hypothermia is strongly recommended for comatose OHCA survivors. Despite this, worldwide implementation of therapeutic hypothermia has been slow. Aims: We aim to evaluate the effectiveness of protocolizing therapeutic hypothermia in a large tertiary hospital and to describe the outcomes of OHCA following its implementation. Methods: We evaluated 964 OHCA patients who presented to the Emergency Department from April 2010 to July 2012. A protocol for therapeutic hypothermia was implemented in June 2011. Data on patients' demographics, initial rhythm of arrest, site of care, institution of therapeutic hypothermia, and neurological outcome on discharge were collected. Results: From April 2010 to July 2012, 964 OHCA patients presented to the Emergency Department and 160 patients survived to admission. The overall OHCA survival-to-hospital-discharge rate was 3.4%; this rate was 2.0% in the first year and 5.1% in the year following the implementation of a protocol (p value ϭ 0.014).
Younger age (odds ratioϭ0.66 per 10 years, pϭ0.003) and a presenting rhythm of ventricular fibrillation/tachycardia (odds ratioϭ7.13, pՅ0.001) were strong predictors of survival to discharge.
The overall rate of implementation of therapeutic hypothermia was 25.8%. Prior to the implementation of a protocol in June 2011, only 8.8% of patients who survived to admission had therapeutic hypothermia. This rate increased significantly to 35.7% in the year following the implementation of a protocol (p valueՅ0.001).
A greater proportion of the patients in the hypothermia group were discharged with good neurological outcome (15% versus 7.8%, p value ϭ 0.217), although the result was not statistically significant. Conclusion: The presence of a protocol led to increasing use of therapeutic hypothermia for comatose OHCA patients in our intensive care units and may have contributed to an improvement in the outcomes of OHCA patients.
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Pretreatment of Synthetic Vascular Grafts With Heparin Before Implantation, A Simple Technique To Reduce The Risk of Thrombosis Rabin Gerrah, Alan R. Hohimer, Rachel E. Sunstrom, Rich D. Reed, Stephen M. Langley Oregon Health and Science University, Portland, OR Background: Synthetic grafts are being widely used to bypass occluded vessels or to supply blood flow. Thrombosis of these grafts is a major complication. The clots are often formed during the first exposure of blood to the graft surface which later become a nidus for larger clots. We examined whether pretreatment of the graft with heparin prevents this initial clotting process. Methods: A circuit was assembled to compare two sets of shunts in the same subject. This circuit simulated a systemic-pulmonary shunt with inflow cannula in the aorta, branching to 2 groups of study and control grafts, connected to an outflow cannula in the pulmonary artery. The study group was treated with heparin for 15 minutes prior to placement in the circuit. With installation of the circuit, the blood flowed from the aorta to a set of multiple branches all the same size and properties with the only difference being exposure to heparin.
Pressure was monitored proximal and distal to the branches to verify similar flow dynamics in each group. After 2 hours of simultaneous and equal flow in all branches the circulation was discontinued and the grafts were irrigated and sliced open to expose the inner surface. Digital images were taken in a standard technique coded for each graft for
